To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Five Questions with Accelmed managing partner Uri Geiger
Accelmed looks to stand out by investing in US-based HealthTech companies that are unlikely to appeal to the traditional private equity fund, taking advantage of its Israel-based team that sources add-ons.
